Skip to main content

Table 4 Percentage of the top 10 most frequently dispensed antidepressants with acceptable vs. non-acceptable compliance in MDD patients with/without HIV/AIDS (dispensed items)

From: The impact of HIV/AIDS on compliance with antidepressant treatment in major depressive disorder: A prospective study in a South African private healthcare cohort

 

HIV + MDD

MDD

  
 

n

Acceptable

n

Unacceptable

n

Acceptable

n

Unacceptable

P***

Cramer’s V

Mirtazapine

40

51.28

38

48.72

848

46.41

979

53.59

0.3987

0.0193

Escitalopram

34

44.16

43

55.84

1781

52.74

1596

47.26

0.1359

−0.0254

Venlafaxine

30

75.00

10

25.00

1972

56.93

1492

43.07

0.0217

0.0388

Citalopram

25

51.02

18

48.92

1002

51.46

945

48.54

0.9511

−0.0014

Fluoxetine

19

41.30

25

58.70

724

47.95

786

52.05

0.3743

−0.0225

Bupropion

18

78.26

5

21.74

714

50.46

701

49.54

0.0082

0.0698

Duloxetine

11

36.67

19

63.33

1284

55.51

1029

44.49

0.0391

−0.0426

Amitriptyline

8

23.53

26

76.47

548

39.34

845

60.66

0.0618

−0.0494

Trazodone

6

27.27

16

72.73

596

50.72

579

49.28

0.0293

−0.0630

Paroxetine

6

28.57

15

71.43

582

54.19

492

45.81

0.0197

−0.0705

  1. ***Chi-square.